293480 — Hana Pharm Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩229bn
- KR₩252bn
- KR₩224bn
- 59
- 68
- 66
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 166,347 | 177,306 | 196,407 | 210,845 | 224,457 |
Cost of Revenue | |||||
Gross Profit | 110,197 | 114,023 | 130,818 | 131,240 | 139,584 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 133,060 | 145,460 | 160,397 | 179,719 | 197,385 |
Operating Profit | 33,287 | 31,845 | 36,010 | 31,126 | 27,072 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 34,862 | 28,495 | 35,847 | 30,718 | 27,907 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28,304 | 14,893 | 28,014 | 24,307 | 22,333 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 28,304 | 14,893 | 28,014 | 24,307 | 22,333 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28,304 | 14,893 | 28,014 | 24,307 | 22,333 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1,628 | 839 | 1,678 | 1,412 | 1,290 |
Dividends per Share |